Dimethyl 5-[(4-fluorophenyl)methyl]pyridine-2,3-dicarboxylate | 959406-82-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: Dimethyl 5-[(4-fluorophenyl)methyl]pyridine-2,3-dicarboxylate
• CAS: 959406-82-7
• 化学式: C₁₆H₁₄FNO₄
• 分子量: 303.29
• InChiKey: WABWUJAZQZXUIQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  65.5
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  Dimethyl 5-[(4-fluorophenyl)methyl]pyridine-2,3-dicarboxylate 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 2.0h， 生成 5-[(4-fluorophenyl)methyl]-2,3-pyridinecarboxylic acid
  参考文献：
  名称：

  Synthesis and Antiviral Activity of 7-Benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV Integrase Inhibitors

  摘要：

  The medicinal chemistry and structure-activity relationships for a novel series of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV-integrase inhibitors are disclosed. Substituent effects were evaluated at the N-1, C-3, and 7-benzyl positions of the naphthyridinone ring system. Low nanomolar IC50 values were achieved in an HIV-integrase strand transfer assay with both carboxylic ester and carboxamide groups at C-3. More importantly, several carboxamide congeners showed potent antiviral activity in cellular assays. A 7-benzyl substituent was found to be critical for potent enzyme inhibition, and an N-(2-methoxyethyl)-carboxamide moiety at C-3 significantly reduced plasma protein binding effects in vitro. Pharmacokinetic data in rats for one carboxamide analogue demonstrated oral bioavailability and reasonable in vivo clearance.

  DOI：

  10.1021/jm801404b
• 作为产物：
  描述：

  2-(4-氟苄基)丙烯醛 、 diethyl 2-aminofumarate 在 对甲苯磺酸 作用下， 以 水 、 正丁醇 为溶剂， 生成 Dimethyl 5-[(4-fluorophenyl)methyl]pyridine-2,3-dicarboxylate
  参考文献：
  名称：

  Synthesis and Antiviral Activity of 7-Benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV Integrase Inhibitors

  摘要：

  The medicinal chemistry and structure-activity relationships for a novel series of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV-integrase inhibitors are disclosed. Substituent effects were evaluated at the N-1, C-3, and 7-benzyl positions of the naphthyridinone ring system. Low nanomolar IC50 values were achieved in an HIV-integrase strand transfer assay with both carboxylic ester and carboxamide groups at C-3. More importantly, several carboxamide congeners showed potent antiviral activity in cellular assays. A 7-benzyl substituent was found to be critical for potent enzyme inhibition, and an N-(2-methoxyethyl)-carboxamide moiety at C-3 significantly reduced plasma protein binding effects in vitro. Pharmacokinetic data in rats for one carboxamide analogue demonstrated oral bioavailability and reasonable in vivo clearance.

  DOI：

  10.1021/jm801404b

文献信息

• Integrase inhibitors
  申请人：Cai R. Zhenhong

  公开号：US20080058315A1

  公开（公告）日：2008-03-06

  Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.

  三环化合物，其受保护的中间体，以及用于抑制HIV整合酶的方法被披露。
• Tricyclic HIV integrase inhibitors: VI. SAR studies of ‘benzyl flipped’ C3-substituted pyrroloquinolines
  作者：Sammy Metobo、Michael Mish、Haolun Jin、Salman Jabri、Rachael Lansdown、Xiaowu Chen、Manuel Tsiang、Matthew Wright、Choung U. Kim

  DOI：10.1016/j.bmcl.2008.12.079

  日期：2009.2

  A series of C3 halobenzyl-substituted tricyclic HIV integrase inhibitors was prepared. Improvement in cell-based inhibitor potency was observed in comparison to previously disclosed tricyclic pyrroloquinolines carrying the 'halobenzyl tail' at the lactam nitrogen. Animal PK for several of the C3-substituted inhibitors was examined, with a dihaloaryl analog achieving good balance in protein-shifted EC50 and t(1/2) in animal PK studies. (C) 2008 Elsevier Ltd. All rights reserved.
• INTEGRASE INHIBITORS
  申请人：Cai Zhenhong R.

  公开号：US20090306054A1

  公开（公告）日：2009-12-10

  Tricyclic compounds of formulae I-III, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
• US8008287B2
  申请人：——

  公开号：US8008287B2

  公开（公告）日：2011-08-30
• [EN] INTEGRASE INHIBITORS<br/>[FR] INHIBITEURS D'INTÉGRASE
  申请人：GILEAD SCIENCES INC

  公开号：WO2007136714A2

  公开（公告）日：2007-11-29

  [EN] Tricyclic compounds, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.
  [FR] L'invention concerne des composés tricycliques, des intermédiaires protégés de ceux-ci, ainsi que des méthodes d'inhibition de l'intégrase du VIH.